Atlas Trials

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Clinical trial NCT05965557 · RECRUITING

Trial details

NCT number
NCT05965557
Sponsor
Geneplus-Beijing Co. Ltd.
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2023-06-19
Primary completion
2027-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.